CompletedNot Applicable

Inflammatory Biomarkers of Pediatric Pulmonary Hypertension

Canada74 participantsStarted 2018-06-20

Plain-language summary

To investigate if the inflammatory protein, high mobility group box 1 (HMGB1), along with other inflammatory mediators, is elevated in pediatric patients with congenital heart disease (CHD) and pulmonary hypertension as compared to those with CHD alone, or with healthy controls.

Who can participate

Age range1 Day – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓patients of any age with congenital cardiac disease coming for catheterization of the right heart, or both the right and left heart.

What they're measuring

Measurement of HGMB1

Timeframe: 1 day

Trial details

NCT IDNCT03581695

SponsorThe Hospital for Sick Children

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-05-11

View on ClinicalTrials.gov More Hypertension, Pulmonary trials